City

Bakersfield (1)

Fort Wayne (1)

Fullerton (1)

Hangzhou (1)

Los Angeles (1)

Nanjing (1)

Orlando (1)

Wichita (1)

Zhengzhou (1)

Condition

Recurrent Extensive Stage Small Cell Lung Carcinoma (2)

Refractory Extensive Stage Small Cell Lung Carcinoma (1)

Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Jonsson Comprehensive Cancer Center (1)

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. (1)

Collaborator

Pfizer (1)

Translational Research in Oncology (1)

Intervention

temozolomide (2)

htmc0435 (1)

talazoparib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

recurrent extensive stage small cell lung carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent Extensive Stage Small Cell Lung Carcinoma Trial in Hangzhou, Nanjing, Zhengzhou (HTMC0435, Temozolomide)

Not yet recruiting

Recurrent Extensive Stage Small Cell Lung Carcinoma

Hangzhou, China
+2 more

Feb 5, 2023

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting

Recurrent Extensive Stage Small Cell Lung Carcinoma
Refractory Extensive Stage Small Cell Lung Carcinoma

Bakersfield, California
+5 more

Jan 5, 2023